4.23
price down icon7.64%   -0.35
after-market Handel nachbörslich: 4.38 0.15 +3.55%
loading

Finanzdaten der X 4 Pharmaceuticals Inc-Aktie (XFOR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
93.78%
1.744
0.90 1.434 0.56 0.563
Cost Of Revenue
93.09%
0.326
4.716 0.302 0.227 0.268
Gross Profit
137.16%
1.418
-3.816 1.132 0.333 0.295
Operating Expenses
391.38%
27.65
5.627 36.85 34.83 -70.81
Benefits Costs and Expenses
4,600%
27.45
0.584 41.00 37.24 -90.29
Costs And Expenses
4,600%
27.45
0.584 40.26 37.24 -90.29
Operating Income/Loss
177.79%
-26.23
-9.443 -35.72 -34.50 71.10
Nonoperating Income/Loss
94.59%
0.528
9.759 -3.848 -2.181 19.75
Income/Loss From Continuing Operations Before Tax
8,234%
-25.70
0.316 -39.56 -36.68 90.85
Income Tax Expense/Benefit
8.82%
0.037
0.034 0.258 0.015 0.018
Income/Loss From Continuing Operations After Tax
9,228%
-25.74
0.282 -39.82 -36.70 90.83
Net Income/Loss
9,228%
-25.74
0.282 -39.82 -36.70 90.83
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
8.38%
7.413
6.84 0.6282 200.87 200.44
Diluted Average Shares
7.92%
7.413
6.8691 0.451 200.87 200.80
Basic Earnings Per Share
8,775%
-3.47
0.04 -0.20 -0.18 0.45
Diluted Earnings Per Share
8,775%
-3.47
0.04 -0.20 -0.18 0.45
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Kapitalisierung:     |  Volumen (24h):